20-hydroxy-5,8,11,14-eicosatetraenoic acid has been researched along with hypochlorous acid in 1 studies
| Studies (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Trials (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Recent Studies (post-2010) (20-hydroxy-5,8,11,14-eicosatetraenoic acid) | Studies (hypochlorous acid) | Trials (hypochlorous acid) | Recent Studies (post-2010) (hypochlorous acid) |
|---|---|---|---|---|---|
| 640 | 13 | 233 | 2,844 | 44 | 1,307 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Azcona, JA; Berry, E; Falck, JR; Garvey, R; Guo, AM; Jeitner, TM; Schwartzman, ML; Tang, S; Yi, T; Zhang, FF | 1 |
1 other study(ies) available for 20-hydroxy-5,8,11,14-eicosatetraenoic acid and hypochlorous acid
| Article | Year |
|---|---|
Neutrophil-Derived Myeloperoxidase and Hypochlorous Acid Critically Contribute to 20-Hydroxyeicosatetraenoic Acid Increases that Drive Postischemic Angiogenesis.
Topics: Animals; Endothelial Cells; Hydroxyeicosatetraenoic Acids; Hypochlorous Acid; Ischemia; Mice; Neovascularization, Pathologic; Neutrophils; Peroxidase | 2022 |